Sensitive detection of 3'-hydroxy-stanozolol glucuronide by liquid chromatography-tandem mass spectrometry

Journal of Chromatography A

Volumn 1292, Issue , 2013, Pages 195-200

  Tudela, E ^a   Deventer, K ^a   Van Eenoo, P ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Doping; Glucuronide; LC MS; SPE; Stanozolol; Urine

Indexed keywords

GLUCURONIDES; LC-MS; SPE; STANOZOLOL; URINE;

BIOMOLECULES; DOPING (ADDITIVES); ENZYMATIC HYDROLYSIS; EXTRACTION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITES;

BODY FLUIDS;

3' HYDROXYSTANOZOLOL GLUCURONIDE; STANOZOLOL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DOPING; DRUG ABUSE; HUMAN; HUMAN EXPERIMENT; INTERMETHOD COMPARISON; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; MALE; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; URINALYSIS; URINARY EXCRETION; VALIDATION PROCESS;

ADULT; ANABOLIC AGENTS; CHROMATOGRAPHY, LIQUID; DOPING IN SPORTS; HUMANS; LIMIT OF DETECTION; MALE; SOLID PHASE EXTRACTION; STANOZOLOL; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY; TIME FACTORS;

EID: 84877130081     PISSN: 00219673     EISSN: 18733778     Source Type: Journal    
DOI: 10.1016/j.chroma.2013.01.001     Document Type: Article

References (34)

1. Celotti F., Negri C.P. J. Steroid. Biochem. Mol. Biol. 1992, 43:469.
2. Lamb D.R. Am. J. Sports Med. 1984, 12:31.
3. Wu F.C.W. Clin. Chem. 1997, 43:1289.
4. The 2012 Prohibited List, International Standard, World Anti-Doping Agency (WADA). 2012 (accessed 30.01.2012). http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/2012/WADA_Prohibited_List_2012_EN.pdf.
5. Sullivan M.L., Martinez C.M., Gennis P., Gallagher E.J. Prog. Cardiovasc. Dis. 1998, 41:1.
6. Maravelias C., Dona A., Stefanidou M., Spiliopoulou C. Toxicol. Lett. 2005, 158:167.
7. Middleman A.B., DuRant R.H. Sports Med. 1996, 21:251.
8. World Anti-Doping Code, World Anti-Doping Agency (WADA). 2009 (accessed 13.01.2011). http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-The-Code/WADA_Anti-Doping_CODE_2009_EN.pdf.
9. Van Eenoo P., Delbeke F.T. J. Steroid Biochem. Mol. Biol. 2006, 101:161.
10. Schanzer W. Clin. Chem. 1996, 42:1001.
11. Clinton R.O., Manson A.J., Stonner F.W., Beyler A.L., Potts G.O., Arnold A. J. Am. Chem. Soc. 1959, 81:1513.
12. 2010 Adverse Analytical Findings and Atypical Findings Reported by Accredited Laboratories, World Anti-Doping Agency (WADA). 2010 (accessed 21.05.2012). http://www.wada-ama.org/Documents/Resources/Testing-Figures/WADA_2010_Laboratory_Statistics_Report.pdf.
13. Masse R., Ayotte C., Bi H., Dugal R. J. Chromatogr. 1989, 497:17.
14. Schaenzer W., Opfermann G., Donike M. J. Steroid Biochem. 1990, 36:153.
15. Schaenzer W., Delahaut P., Geyer H., Machnik M., Horning S. J. Chromatogr. B 1996, 687:93.
16. Pozo O.J., Van Eenoo P., Deventer K., Lootens L., Grimalt S., Sancho J.V., Hernandez F., Meuleman P., Leroux-Roels G., Delbeke F.T. Steroids 2009, 74:837.
17. Marcos J., Pascual J.A., De l.T.X., Segura J. J. Mass Spectrom. 2002, 37:1059.
18. Schaenzer W., Donike M. Anal. Chim. Acta 1993, 275:23.
19. Muck W.M., Henion J.D. Biomed. Environ. Mass Spectrom. 1990, 19:37.
20. Thevis M., Fussholler G., Geyer H., Rodchenkov G., Mareck U., Sigmund G., Koch A., Thomas A., Schanzer W. Chromatographia 2006, 64:441.
21. Guddat S., Thevis M., Kapron J., Thomas A., Schanzer W. Drug Test. Anal. 2009, 1:545.
22. Mateus-Avois L., Mangin P., Saugy M. J. Chromatogr. B 2005, 816:193.
23. Pozo O.J., Van Eenoo P., Van Thuyne W., Deventer K., Delbeke F.T. J. Chromatogr. A 2008, 1183:108.
24. McKinney A.R., Suann C.J., Dunstan A.J., Mulley S.L., Ridley D.D., Stenhouse A.M. J. Chromatogr. B 2004, 811:75.
25. Van de Wiele M., De Wasch K., Vercammen J., Courtheyn D., De Brabander H., Impens S. J. Chromatogr. A 2000, 904:203.
26. Technical Document - TD2010IDCR, Identification criteria for qualitative assays incorporating column chromatography and mass spectrometry, World Anti-Doping Agency (WADA). 2010 (accessed 13.08.2011). http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-IS-Laboratories/WADA_TD2010IDCRv1.0_Identification%20Criteria%20for%20Qualitative%20Assays_May%2008%202010_EN.doc.pdf.
27. Ahi S., Reddy I.M., Beotra A., Lal R., Jain S., Kaur T. Indian J. Pharmacol. 2008, 40:164.
28. International Standard for Laboratories, version 7.0, World Anti-Doping Agency (WADA). 2012 (accessed 13.01.2012). http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-IS-Laboratories/ISL/WADA_Int_Standard_Laboratories_2012_EN.pdf.
29. The fitness for purpose of analytical methods. A laboratory guide to method validation and related topics, Eurachem, Teddington, 1998.
30. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Anal. Chem. 2003, 75:3019.
31. Kuuranne T., Vahermo M., Leinonen A., Kostiainen R. J. Am. Soc. Mass Spectrom. 2000, 11:722.
32. Buiarelli F., Coccioli F., Merolle M., Neri B., Terracciano A. Anal. Chim. Acta 2004, 526:113.
33. Badoud F., Grata E., Boccard J., Guillarme D., Veuthey J.L., Rudaz S., Saugy M. Anal. Bioanal. Chem. 2011, 400:503.
34. Bowers L.D., Sanaullah J. Chromatogr. B 1996, 687:61.